Sun Pharma announces USFDA approval for generic Xanax® Tablets

17/B, Mahal Industrial Estate, Mahakali Caves Road, Andheri (East), Mumbai 400 093 India Tel.: (91-22) 6645 5645 Fax.: (91-22) 6645 5685 Registered Office : SPARC, Tandalja, Vadodara – 390 020. India Corporate Office : Acme Plaza, Andheri – Kurla Road, Andheri (East), Mumbai – 400 059. India FOR IMMEDIATE RELEASE Sun Pharma announces USFDA approval for generic Xanax ® Tablets Mumbai, June 18, 2010: Sun Pharma announced that USFD A has granted an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Xanax ®, alprazolam tablets. These generic alprazolam tablets, equivalent to Pfizer’s Xanax ® tablets, include four strengths: 0.25 mg, 0.5 mg, 1 mg and 2 mg. Annual sale in US for these strengths of branded and generic alprazolam tablets is estimated at $ 145 million. Alprazolam tablets are indicated for the management of an xiety disorder or the short-term relief of symptoms of anxiety. It is also indicated for the treatment of panic disorder, with our without agoraphobia. Xanax ® is a registered trademark of Pfizer. About Sun Pharmaceutical Industries Ltd. Established in 1983, listed since 1994 and headquartered in Indi a, Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) is an intern ational, integrated, speciality pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulat ions as branded generics as well as generics in India, US and several other markets across the world. In India, the compan y is a leader in niche therapy areas of psychiatry, neurology, cardiology, diabetology, gastroenterolo gy, orthopedics and ophthalmology. The Company has strong skills in product development, process chemistry, and manuf acturing of complex API, as well as do sage forms. More information about the company can be found at www.sunpharma.com. Contacts Uday Baldota Mira Desai Tel +91 22 6645 5645, Xtn 605 Tel +91 22 6645 5645, Xtn 606 Tel Direct +91 22 66455605 Tel Direct +91 22 66455606 Mobile +91 98670 10529 Mobile +91 98219 23797 E mail [email protected] E mail [email protected]

The release as fetched from its publisher. sunpharma.com ↗